loadpatents
name:-0.016447067260742
name:-0.004892110824585
name:-0.00039911270141602
Meingassner; Josef Gottfried Patent Filings

Meingassner; Josef Gottfried

Patent Applications and Registrations

Patent applications and USPTO patent grants for Meingassner; Josef Gottfried.The latest application filed is for "kallikrein 7 modulators".

Company Profile
0.7.17
  • Meingassner; Josef Gottfried - Vienna AT
  • MEINGASSNER; Josef Gottfried - Perchtoldsdorf AT
  • Meingassner, Josef Gottfried - Perhtoldsdorf AT
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Cyclic depsipeptides
Grant 9,127,044 - Krastel , et al. September 8, 2
2015-09-08
Kallikrein 7 Modulators
App 20130028843 - FLOHR; Stefanie ;   et al.
2013-01-31
Kallikrein 7 modulators
Grant 8,309,596 - Flohr , et al. November 13, 2
2012-11-13
Cyclic Depsipeptides
App 20120196790 - KRASTEL; Philipp ;   et al.
2012-08-02
Cyclic depsipeptides
Grant 8,178,650 - Krastel , et al. May 15, 2
2012-05-15
Pharmaceutical Compositions and Solid Forms
App 20110112121 - BERGHAUSEN; Joerg ;   et al.
2011-05-12
Kallikrein 7 modulators
App 20100256144 - Flohr; Stefanie ;   et al.
2010-10-07
Anti-inflammatory Compounds
App 20090227620 - Meingassner; Josef Gottfried
2009-09-10
Combination of a Steroid Sulfatase Inhibitor and an Ascomycin
App 20080293758 - Meingassner; Josef Gottfried
2008-11-27
Antiinflammatory lactones
Grant 7,414,074 - Meingassner , et al. August 19, 2
2008-08-19
Use Of A Steroid For Enhancement Of Skin Permeability
App 20080171729 - Meingassner; Josef Gottfried
2008-07-17
Use of mGluR5 antagonists for the treatment of pruritic conditions
App 20070265279 - Gasparini; Fabrizio ;   et al.
2007-11-15
Antiinflammatory Lactones
App 20070219143 - Meingassner; Josef Gottfried ;   et al.
2007-09-20
Diazepanes derivatives useful as ifa inhibitors
App 20060148780 - Oberhauser; Berndt ;   et al.
2006-07-06
Combination of a macrolide t-cell immunomodulator and a calciferol for the treatment of skin diseases or of inflammatory bowel disease
App 20060106003 - Grassberger; Maximillian ;   et al.
2006-05-18
Synergistic combinations of macrolide t-cell modulator or immunosuppressant and a retinoid
App 20060100187 - Grassberger; Maximilian ;   et al.
2006-05-11
New use of 11.28-dioxa-4-azatricyclo [22.3.1.04,9] octacos-18-ene derivatives and pharmaceutical compositions containing them
App 20050059694 - Grassberger, Maximimilian ;   et al.
2005-03-17
Melvinolin derivatives
Grant 6,818,638 - Baenteli , et al. November 16, 2
2004-11-16
Macrolides containing pharmaceutical compositions
App 20040192716 - Meingassner, Josef Gottfried
2004-09-30
Use of mglur5 antagonists for the treatment of pruritic conditions
App 20040106582 - Gasparini, Fabrizio ;   et al.
2004-06-03
Mevinolin derivatives
App 20030087903 - Baenteli, Rolf ;   et al.
2003-05-08
Mevinolin derivatives
App 20020037895 - Baenteli, Rolf ;   et al.
2002-03-28
Use of 11,28-dioxa-4-azatricyclo[22.3.1.0.sup.4,9 ]octacos-18-ene derivatives and pharmaceutical compositions containing them
Grant 5,665,727 - Grassberger , et al. September 9, 1
1997-09-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed